| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 140/Kit
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Product Description: B7-33 is a synthetic peptide derived from the H2 relaxin family, specifically engineered to target the relaxin hormone receptor RXFP1. This peptide has shown promising results in cardiovascular and fibrosis research, offering potential therapeutic benefits in treating heart failure, kidney fibrosis, and other related conditions. The 6mg dosage of B7-33 raw material provides a precise concentration suitable for research and development purposes, facilitating studies aimed at understanding its mechanism of action and exploring its efficacy in clinical settings. B7-33 is recognized for its ability to modulate tissue remodeling and inflammation, making it a valuable tool in the development of novel treatments for fibrotic diseases.
Manufacturing Excellence: Our B7-33 is produced under strict GMP conditions, ensuring the highest purity and quality. The synthesis process is rigorously controlled to produce a stable and effective peptide suitable for research and potential therapeutic use.
Applications: B7-33 is primarily used in cardiovascular and fibrotic disease research. It is investigated for its effects on heart function, kidney health, and its anti-fibrotic properties, potentially offering new avenues for treatment development in chronic disease management.
| Product Name | B7-33 |
| CAS NO. | 62304-98-7 |
| Appearance | White freeze-dried powder |
| Purity | 98% HPLC |
| Application | Research peptides |
| Shelf Life | 24 Months |
| Storage | Store at a temperature of 2-8 degrees, protected from light. |
Goods quality
){kind=link}